<DOC>
	<DOCNO>NCT00419419</DOCNO>
	<brief_summary>The purpose research study test safety , tolerability , effectiveness Topical AmphiMatrix Nitroglycerin ( MQX-503 ) relieve Raynaud 's symptom increase blood flow finger .</brief_summary>
	<brief_title>Phase III Study Topical Gel Formulation Treatment Prevention Raynaud 's Phenomenon</brief_title>
	<detailed_description>The purpose clinical study determine , control fashion , ability Topical AmphiMatrix formulation Nitroglycerin ( MQX-503 ) improve patient 's health assessment indicate patient physician assessment , decrease frequency Raynaud 's event , decrease duration Raynaud 's event , decrease symptom ( pain , tingling , numbness ) finger Raynaud 's patient . The study include patient moderate severe primary Raynaud 's phenomenon Raynaud 's phenomenon secondary autoimmune disease scleroderma .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Outpatients , 18 year 70 year . Patients clinical diagnosis Raynaud ’ phenomenon . Patients willing discontinue current vasodilator therapy . Patients agree use investigational medication approve therapy treat Raynaud ’ phenomenon symptom participate study . Negative pregnancy test fertile woman . Patients able give write informed consent comply study requirement . Patients concurrently use nitrate medication medication know interact Nitroglycerin . Patients concurrently use medication device might interfere study medication . Patients know allergy Nitroglycerin common topical gel ingredient . Patients history headache . Patients history unstable medical problem . Patients cognitive language difficulty . Patients , within past three month , either myocardial infarction , uncontrolled congestive heart failure , unstable angina , uncontrolled hypotension , uncontrolled hypertension . Patients participate study investigational drug within four week prior Visit 1 . Patients screen laboratory value 20 % great upper low limit normal . Patients major surgery within six month Visit 1 . Patients interfere skin condition . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Raynaud 's</keyword>
</DOC>